Helicobacter Pylori
Probiotic supplementation improves tolerance to H. pylori eradication therapy
Published in TB and Outbreaks Week, November 15th, 2005
According to recent research from Finland, "H. pylori is the major cause of chronic gastritis, and a risk factor for peptic ulcer and gastric cancer. To investigate the effect of probiotic supplementation on the tolerance and efficacy of H. pylori eradication treatment in a randomized, double-blind, placebo-controlled trial."
"A total of 338 volunteers were screened for H. pylori infection. The eligibility criteria were met by 47 subjects whose H. pylori infection was verified at the outset and re-evaluated after the treatment...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Adenovirus Outbreaks
B2 adenovirus was the cause of a respiratory disease outbreak in a military camp - Epidemiology
Pontiac fever outbreak associated with exposure to hotel pool/spa area - Food Safety
Mycobacterium avium subsp paratuberculosis detected in powdered infant milk - Norovirus Outbreaks
Majority of Norovirus outbreaks transmitted by human contact - Respiratory Medicine
Pneumonia and pulmonary TB most common respiratory tract infections in hospitalized travelers - Adverse Drug Reaction
Male SARS patients have reduced bone mineral density due to prolonged steroid therapy - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
